Catheter-Directed Thrombolysis Along with Mechanical Thromboaspiration versus Anticoagulation Alone in the Management of Lower Limb Deep Venous Thrombosis—A Comparative Study
Abstract:Catheter-directed thrombolysis (CDT) with assisted mechanical thrombolysis is now considered as the standard of medical care for deep vein thrombosis (DVT). The study was conducted to describe the immediate and long-term (6 months) safety and effectiveness of CDT in patient with lower limb DVT compared with the routine anticoagulation alone. All 12 to 85 years old patients with recent (0?8 weeks) DVT were included. In CDT group, thrombus was aspirated mechanically and streptokinase (STK) was given along with u… Show more
“…The primary endpoint of this study was to determine the efficacy of PMT (CDT and mechanical thromboaspiration) in comparison to standard anticoagulation alone. 8 Kuo et al included 61 patients with acute ilieofemoral DVT in a prospective study with the main objective of comparing the efficacy, long-term outcomes and complications of CDT and PMT treatment. 5 In this trial, performed in 2016, 3 patients were submitted to CDT and 31 patients were submitted to PMT, pursuant to each patient's decision.…”
Section: Resultsmentioning
confidence: 99%
“…The risk of bias assessment of the 4 included randomized clinical trials and the 5 non-randomized comparative studies is presented in Table I, II, 5,8,9,[11][12][13][14] respectively.…”
Section: Risk Of Biasmentioning
confidence: 99%
“…In case of disagreement, a third reviewer was responsible for the analysis of the study and extracted data in cause and a team discussion was made in order to achieve common Table II.-Risk of bias assessment of the included nonrandomized clinical trials, according to the NewCastle Ottawa Scale (NOS). 5,8,9,13,14 Srinivas et al 8 Kuo et al 5 lin et al 13 Huang et al 9 Martinez et al 14 good quality: 3 or 4 stars in selection domain aND 1 or 2 stars in comparability domain aND 2 or 3 stars in outcome/exposure domain; Fair quality: 2 stars in selection domain aND 1 or 2 stars in comparability domain aND 2 or 3 stars in outcome/exposure domain; Poor quality: 0 or 1 star in selection domain or 0 stars in comparability domain or 0 or 1 stars in outcome/exposure domain.…”
Section: Data Extractionmentioning
confidence: 99%
“…The most relevant characteristics of each of these studies are described in Table III. 2,4,5,8,9,[11][12][13][14] CaVenT 2 and Haig et al 11 are two different trials that studied the same baseline population. In order to avoid including duplicated data in the statistical analysis, we only included Haig et al 11 data in the meta-analysis, because of the longer follow-up period of this study.…”
Section: Selectionmentioning
confidence: 99%
“…From these studies, 4 are prospective randomized clinical trials, 2 are nonrandomized prospec- Table III.-Baseline characteristics of the included studies for meta-analysis. 2,4,5,8,9,[11][12][13][14] evaluated the clinical records of all patients with symptomatic lower leg DVT undergoing CDT or PMT interventions for a 8 year period. 13 A total of 93 patients who were submitted to these endovascular procedures were included in the study.…”
Section: Evidence Synthesis Study Designs and Baseline Characteristicsmentioning
Introduction: Post-thrombotic syndrome (PTS) and iliofemoral (IF) patency reduction are common complications of iliofemoral deep venous thrombosis (IFDVT). Recent studies suggested that endovascular treatment, such as catheter-directed thrombolysis (CDT) and pharmacomechanical thrombectomy (PMT) can effectively reduce the risk and morbidity of PTS in IFDVT patients. This article aims to review the current literature on the subject, focusing on the long-term outcomes of endovascular treatment techniques in IFDVT patients. Evidence acquisition: A thorough systematic review of the literature was conducted using PubMed/Medline and Scopus, according to PRISMA statement guidelines. Forty articles were included, according to their scientific relevance, for the qualitative analysis. From this initial set of articles, nine articles were included for the quantitative analysis. Evidence synthesis: Endovascular treatment with CDT or PMT is related to a decreased risk of PTS development, when compared to standard anticoagulation treatment (OR=0.71; 95% CI=0.54-0.92). Furthermore, IF patency presents superior rates in patients treated with CDT or PMT, instead of anticoagulation (OR=3.20; 95% CI=1.80-5.71). There are no significant differences in the risk of PTS and IF patency between patients treated with CDT and PMT. Complications such as bleeding, pulmonary embolism and death, don't seem to differ between endovascular treatment and anticoagulation, as well as between CDT and PMT procedures. Conclusions: Endovascular techniques seem to have satisfactory long-term outcomes in IFDVT, regarding to PTS risk and IF patency. However, further investigation with prospective randomized clinical trials with large populations and long follow-ups is necessary.
“…The primary endpoint of this study was to determine the efficacy of PMT (CDT and mechanical thromboaspiration) in comparison to standard anticoagulation alone. 8 Kuo et al included 61 patients with acute ilieofemoral DVT in a prospective study with the main objective of comparing the efficacy, long-term outcomes and complications of CDT and PMT treatment. 5 In this trial, performed in 2016, 3 patients were submitted to CDT and 31 patients were submitted to PMT, pursuant to each patient's decision.…”
Section: Resultsmentioning
confidence: 99%
“…The risk of bias assessment of the 4 included randomized clinical trials and the 5 non-randomized comparative studies is presented in Table I, II, 5,8,9,[11][12][13][14] respectively.…”
Section: Risk Of Biasmentioning
confidence: 99%
“…In case of disagreement, a third reviewer was responsible for the analysis of the study and extracted data in cause and a team discussion was made in order to achieve common Table II.-Risk of bias assessment of the included nonrandomized clinical trials, according to the NewCastle Ottawa Scale (NOS). 5,8,9,13,14 Srinivas et al 8 Kuo et al 5 lin et al 13 Huang et al 9 Martinez et al 14 good quality: 3 or 4 stars in selection domain aND 1 or 2 stars in comparability domain aND 2 or 3 stars in outcome/exposure domain; Fair quality: 2 stars in selection domain aND 1 or 2 stars in comparability domain aND 2 or 3 stars in outcome/exposure domain; Poor quality: 0 or 1 star in selection domain or 0 stars in comparability domain or 0 or 1 stars in outcome/exposure domain.…”
Section: Data Extractionmentioning
confidence: 99%
“…The most relevant characteristics of each of these studies are described in Table III. 2,4,5,8,9,[11][12][13][14] CaVenT 2 and Haig et al 11 are two different trials that studied the same baseline population. In order to avoid including duplicated data in the statistical analysis, we only included Haig et al 11 data in the meta-analysis, because of the longer follow-up period of this study.…”
Section: Selectionmentioning
confidence: 99%
“…From these studies, 4 are prospective randomized clinical trials, 2 are nonrandomized prospec- Table III.-Baseline characteristics of the included studies for meta-analysis. 2,4,5,8,9,[11][12][13][14] evaluated the clinical records of all patients with symptomatic lower leg DVT undergoing CDT or PMT interventions for a 8 year period. 13 A total of 93 patients who were submitted to these endovascular procedures were included in the study.…”
Section: Evidence Synthesis Study Designs and Baseline Characteristicsmentioning
Introduction: Post-thrombotic syndrome (PTS) and iliofemoral (IF) patency reduction are common complications of iliofemoral deep venous thrombosis (IFDVT). Recent studies suggested that endovascular treatment, such as catheter-directed thrombolysis (CDT) and pharmacomechanical thrombectomy (PMT) can effectively reduce the risk and morbidity of PTS in IFDVT patients. This article aims to review the current literature on the subject, focusing on the long-term outcomes of endovascular treatment techniques in IFDVT patients. Evidence acquisition: A thorough systematic review of the literature was conducted using PubMed/Medline and Scopus, according to PRISMA statement guidelines. Forty articles were included, according to their scientific relevance, for the qualitative analysis. From this initial set of articles, nine articles were included for the quantitative analysis. Evidence synthesis: Endovascular treatment with CDT or PMT is related to a decreased risk of PTS development, when compared to standard anticoagulation treatment (OR=0.71; 95% CI=0.54-0.92). Furthermore, IF patency presents superior rates in patients treated with CDT or PMT, instead of anticoagulation (OR=3.20; 95% CI=1.80-5.71). There are no significant differences in the risk of PTS and IF patency between patients treated with CDT and PMT. Complications such as bleeding, pulmonary embolism and death, don't seem to differ between endovascular treatment and anticoagulation, as well as between CDT and PMT procedures. Conclusions: Endovascular techniques seem to have satisfactory long-term outcomes in IFDVT, regarding to PTS risk and IF patency. However, further investigation with prospective randomized clinical trials with large populations and long follow-ups is necessary.
BackgroundStandard treatment for deep vein thrombosis (DVT) aims to reduce immediate complications. Use of thrombolytic clot removal strategies (i.e., thrombolysis (clot dissolving drugs) with or without additional endovascular techniques), could reduce the long-term complications of post-thrombotic syndrome (PTS) including pain, swelling, skin discolouration, or venous ulceration in the affected leg. This is the fourth update of the review first published in 2004.
There were no randomised controlled trials that assessed the effects of pharmacomechanical thrombectomy versus anticoagulation (alone or with compression stockings), mechanical thrombectomy, thrombolysis, or other endovascular techniques in the management of people with acute DVT of the iliofemoral vein that met the eligibility criteria for this review. Further high quality randomised controlled trials are needed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.